Direct. Last minute on the coronavirus
UK was the first country in the world to approve the vaccine against the
coronavirus
, of
Pfizer / BionTech
.
And now, he is also the one that takes the lead when it comes to launching a highly questioned proposal: the combination of doses from different pharmaceutical companies.
In other words, it is accepted that patients can receive the
AstraZeneca
version in the
absence
of
stocks
.
This decision is not accompanied by scientific evidence and is causing rejection by other countries.
What are the reasons?
Pod
Become Premium and
enjoy 3 months for € 1
Take advantage of this limited time offer and access all web content
I want it
Are you already Premium?
Log in
Cancel whenever you want
Check the terms and conditions of the service
According to the criteria of The Trust Project
Know more